• 1
    Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10–13 weeks gestation. Hum Reprod 2002;17(1):9298.DOI: 10.1093/humrep/17.1.92
  • 2
    Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 2002;109(11):12811289.
  • 3
    Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62(6):297303.
  • 4
    Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994;9(11):21672172.
  • 5
    Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338(18):12411247.DOI: 10.1056/NEJM199804303381801
  • 6
    Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69(1):5158.
  • 7
    Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106(7):706710.
  • 8
    OFNS. Abortion Statistics: Series AB No. 28. Legal Abortion in England and Wales 2001. London: Office for National Statistics, 2002.
  • 9
    Information and Statistics Division. Abortion Statistics in Scotland 2002—ISD Scotland Health Briefing. Edinburgh: ISD, 2003.
  • 10
    UK Multicentre Study Group. Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. Contraception 1997;56(6):361366.
  • 11
    UK Multicentre Study—Final Results. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study—final results. Contraception 1997;55(1):15.
  • 12
    UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial. Br J Obstet Gynaecol 1990;97(6):480486.
  • 13
    Westhoff C, Dasmahapatra R, Winikoff B, Clarke S. Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group. Contraception 2000;61(3):225229.
  • 14
    Westhoff C, Dasmahapatra R, Schaff E. Analgesia during at-home use of misoprostol as part of a medical abortion regimen. Contraception 2000;62(6):311314.
  • 15
    Grimes DA. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997;89(5 Pt 1):790796.
  • 16
    Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13(10):29622965.
  • 17
    Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9–13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet 1998;352(9127):542543.
  • 18
    Hamoda H, Ashok PW, Flett GMM, Templeton A. Medical abortion at 64 to 91 days gestation: a review of 483 consecutive cases. Am J Obstet Gynecol 2003;188(5):13151319.
  • 19
    Robinson HP. Sonar measurement of fetal crown–rump length as means of assessing maturity in first trimester of pregnancy. BMJ 1973;4(5883):2831.
  • 20
    El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332(15):983987.